ENDONOVO THERAPEUTICS, INC. (ENDV) Operating income 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) annual operating income history from SEC filings — each fiscal year as reported.
-$3.3MFY2022 · since FY2013: -$2.4M → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$3.3M | -46.6% |
| FY2021 | -$2.2M | +23.5% |
| FY2020 | -$2.9M | +23.5% |
| FY2019 | -$3.8M | +8.4% |
| FY2018 | -$4.2M | +9.7% |
| FY2017 | -$4.6M | +14.9% |
| FY2016 | -$5.4M | -111.0% |
| FY2015 | -$2.6M | -17.0% |
| FY2014 | -$2.2M | +9.8% |
| FY2013 | -$2.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENDV financial trends
ENDV RevenueENDV Net incomeENDV Net marginENDV Gross profitENDV Gross marginENDV Operating marginENDV Operating cash flowENDV Free cash flowENDV Capital expendituresENDV Return on equityENDV Stock buybacksENDV Dividends paidENDV Total assetsENDV Total liabilitiesENDV Shareholders’ equityENDV overview →